15/09/2008 07:00:00

Ratan Tata Joins Nanobiosym Global Advisory Board

Nanobiosym®, a leading nanotechnology firm,

today announced that Mr.

Ratan Tata, chairman of the multibillion-dollar global conglomerate

Tata Group, has joined the firms global

advisory board.

I am honored to welcome Mr. Tata to our

Global Advisory Board, said Nanobiosym®

Chairman and CEO, Dr.

Anita Goel, MD, PhD- a Harvard and MIT-trained physicist and

physician. I am inspired by his example,

which provides us with a practical roadmap for bringing cutting edge

technologies into emerging global economies and extending our reach to

broad markets at the bottom of the pyramid.

Nanobiosym® has developed Gene-RADAR®,

a portable nanotechnology platform that can rapidly and accurately

detect genetic fingerprints from any biological organism. Dr. Goels

vision is to give patients worldwide real-time access to their own

diagnostic information through low-cost handheld devices that could

detect disease from a single drop of blood or saliva.

Nanotechnology has the potential to

revolutionize the way we tackle key issues facing the world today, and

Nanobiosym® is working at the forefront of

this revolution, Mr. Tata said. Dr.

Goel has forged a bold model for driving technological innovation and

commercialization, while maximizing global humanitarian impact. I am

delighted to join the Nanobiosym® Global

Advisory Board, and I look forward to working closely with Dr. Goel and

her team.

Mr. Alfred Ford, Director of the Ford Motor Company Fund and also a

member of the Nanobiosym® Global Advisory

Board, said: Behind this vision is

game-changing technology which can revolutionize healthcare globally. In

the face of growing world health crises and transnational epidemics, Dr.

Goel and Nanobiosym® are redefining the rules

in the battle to diagnose disease and save lives.

Imagine the possibilities when a pioneer like Dr. Goel, named one of MIT

Technology Reviews top 35 science and

technology innovators in the world, aligns with a global entrepreneur

like Mr. Tata, named one of Time Magazines

100 most influential people in the world. Very big - and very, very

small - things can happen.

Dr. Goel sees far over the horizon, beyond

geographic and technological boundaries, and envisions technology driven

by the needs of the greater good -- a vision that we both share,

Mr. Tata said.

The Nanobiosym Chairman and CEO added, We

are deeply committed to bringing our nanotech innovations into global

markets to address some of the greatest unmet humanitarian needs of our



Nanobiosym (www.nanobiosym.com)

Nanobiosym® and its commercial engine

Nanobiosym® Diagnostics create and

commercialize breakthrough technologies at the nexus of physics,

biomedicine, and nanotechnology. Its Gene-RADAR®

technology platform will empower people worldwide with rapid, accurate

and portable diagnostic information about their own health. Nanobiosyms®

Global Advisory Board comprises global thought leaders who provide

guidance and strategic vision to help Nanobiosym®

realize its mission. Nanobiosym® and its

Board work closely with governmental, NGO, and commercial partners to

bring its revolutionary technology platforms into developed and emerging

world markets.

About Dr.

Anita Goel

Dr. Anita Goel, M.D., Ph.D., Chairman and CEO of Nanobiosym®,

is an internationally recognized nanotech expert and entrepreneur. Dr.

Goels pioneering contributions to the

interface of physics, medicine, and nanotechnology over the past 15

years have been recognized globally by several prestigious honors and

funding awards from the United States Department of Defense agencies

including Defense Advanced Research Projects Agency (DARPA), Air Force

Office of Scientific Research (AFOSR), U.S. Department of Energy (DOE)

and the U.S. Defense Threat Reduction Agency (DTRA). In 2005 Dr. Goel

was named one of the worlds Top

35 Science and Technology Innovators under the age of 35

by MITs Technology Review magazine

and in 2006 received MITs Global Indus

Technovator Award, an honor that recognizes the contributions of the top

10 leaders working globally at the forefront of science, technology, and

entrepreneurship. Dr. Goel holds both a Ph.D. in physics from Harvard

University and an M.D. from the Harvard-MIT Joint Division of Health

Sciences and Technology (HST).

About Mr.

Ratan N. Tata

Mr. Ratan N. Tata is Chairman of Tata Sons, the holding company for the

Tata Group, the multibillion dollar Indian conglomerate. He is also the

Chairman of two of the largest philanthropic trusts in India. Mr. Tata

is a member of the Asia-Pacific Advisory Committee to the Board of

Directors of the New York Stock Exchange and the International Advisory

Council of Singapore´s Economic Development Board, and of the advisory

boards of the Mitsubishi Corporation, JP Morgan Chase and Rolls Royce.

Mr. Tata serves as President of the Court of the Indian Institute of

Science and Chairman of the Tata Institute of Fundamental Research. He

is a member of the Board of Trustees of Cornell University and the

University of Southern California, as well as the Global Business

Council on HIV/AIDS and the Program Board of the Gates Foundation´s

India AIDS Initiative. He was recently named one of Time Magazine´s ´100

Most Influential People of 2008,´

For Nanobiosym

Media Relations:

Jen Wilson,



Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
15 Sep
  Jeg forstår ikke, at EI tillader en skribent som Baronen84, at forpeste hele forummet med løgn, hå..
15 Sep
FUCK, hvor er disse to usympatiske individer belastende. Ved godt jeg ikke burde starte denne tråd, ..
18 Sep
Goodwrench, sikke en omgang vrøvl.   Det er ikke kun hyklerisk, men også dybt patetisk, når du komme..
15 Sep
Jeg tillader mig at starter en ny tråd med det som jeg har skrevet tidligere til den hån Baron84 har..
15 Sep
Har vel tabt omkring 225K men det er ikke det værste. Det værste er at der så stadig ikke er en orde..
16 Sep
Personligt vil jeg jo sige, at nu er der det gode til BN tilbage, så hvis man fik en over snuden så ..
19 Sep
Her er min model ;)      
16 Sep
Først - surt show - been there, done that - så kender følelsen! Har set mange som har skrevet - at ..
17 Sep
er højt i kurs her  .   Det er synd, at voksne mennesker ikke har mere pli, så snart de er anonyme .
16 Sep
Kære EnKommentar   Ja, det var noget af en lussing, men vi har faktisk siddet med data, uden rigtigt..

P. Schoenfeld Asset Management LLP : Form 8.3 - Booker Group plc

20/09/2017 15:00:11
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: P. Schoenfeld Asset Management LLP (b) Owner or..

Invesco Ltd. : Form 8.3 - Tesco Plc

20/09/2017 13:57:19
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser:   Invesco Ltd. (b) Owner or control..

Form 8.5 (EPT/RI) - Booker Group Plc

20/09/2017 08:10:36
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY 1.         KEY INFORMATION (a) Name of exempt principal trader:   Investec Bank plc   (b) Name of offeror/offeree in relation to whose relevant se..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
Iovance Biotherapeutics, Inc. Announces Pricing of Its Public Offering of $50 Million of Common Stock
Student Transportation Inc. Reports Fourth Quarter & Fiscal Year 2017 Results
The Bonduelle Group received the 1st prize for the Corporate Governance of mid-cap companies
MotivAction Again Named as One of the Top 25 Meeting and Incentive Companies on MeetingsNet CMI 25 List
Telenor completes its sell-down in VEON

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
21 September 2017 09:26:38
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: ReleaseBuild_20170919.1 - EUROWEB2 - 2017-09-21 10:26:38 - 2017-09-21 09:26:38 - 1000 - Website: OKAY